Matching-Adjusted Indirect Comparison for Time-to-Event Endpoints

Yixin Fang Co-Author
AbbVie
 
Moming Li First Author
AbbVie
 
Moming Li Presenting Author
AbbVie
 
Tuesday, Aug 5: 9:20 AM - 9:25 AM
2459 
Contributed Speed 
Music City Center 
To support Health Teachnology Assessment (HTA) submission, we often need to conduct indirect treatment comparisons (ITC). One of the most popular ITC methods is the Matching-Adjusted Indirect Comparison (MAIC), where the individual patient data (IPD) in one trial and the aggregate data (AgD) in another trial are compared for certain endpoints of interest adjusting for between-trial differences in the covariate distribution that influence outcome. In this abstract, we propose a unified approach using pseudo-value for MAIC with time-to-event (TTE) endpoints with MAIC, including survival rate, restricted mean survival time, and competing risks.

Keywords

competing risks

HTA

MAIC

restricted mean survival time

time-to-event 

Main Sponsor

Biopharmaceutical Section